13F HOLDINGS REPORT
Vivo Capital, LLC
Quarter ended Q4 2024 · Filed February 13, 2025 · Accession 0001213900-25-013306
Total Value
$892.6M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Soleno Therapeutics Inc | SLNO | 6,291,851 | $282.8M | 31.68% |
| 2 | Verona Pharma PLC | 925050106 | 2,283,975 | $106.1M | 11.88% |
| 3 | Geron Corp | GERN | 27,225,292 | $96.4M | 10.80% |
| 4 | Terns Pharmaceuticals Inc | TERN | 6,895,746 | $38.2M | 4.28% |
| 5 | Avadel Pharmaceuticals PLC | G29687103 | 2,684,109 | $28.2M | 3.16% |
| 6 | Dyne Therapeutics Inc | DYN | 1,114,960 | $26.3M | 2.94% |
| 7 | Aclaris Therapeutics, Inc. | ACRS | 8,888,888 | $22.0M | 2.47% |
| 8 | Delcath Systems, Inc. | DCTH | 1,708,579 | $20.6M | 2.30% |
| 9 | Viridian Therapeutics Inc | VRDN | 982,576 | $18.8M | 2.11% |
| 10 | Cidara Therapeutics, Inc. | 171757206 | 670,600 | $18.0M | 2.02% |
| 11 | Erasca Inc | ERAS | 6,756,756 | $17.0M | 1.90% |
| 12 | Trevi Therapeutics Inc | TRVI | 3,487,903 | $14.4M | 1.61% |
| 13 | Astria Therapeutics Inc | 04635X102 | 1,552,685 | $13.9M | 1.56% |
| 14 | Rezolute Inc | RZLT | 2,797,704 | $13.7M | 1.54% |
| 15 | Sera Prognostics Inc | SERA | 1,650,440 | $13.4M | 1.51% |
| 16 | Tourmaline Bio Inc. | 89157D105 | 591,882 | $12.0M | 1.34% |
| 17 | Corvus Pharmaceuticals Holdings | CRVS | 2,234,566 | $12.0M | 1.34% |
| 18 | Instil Bio Inc | TIL | 585,485 | $11.2M | 1.25% |
| 19 | Oric Pharmaceuticals Inc | ORIC | 1,277,818 | $10.3M | 1.16% |
| 20 | Abeona Therapeutics, Inc. | ABEO | 1,842,751 | $10.3M | 1.15% |
| 21 | Zenas Biopharma Inc | ZBIO | 1,183,260 | $9.7M | 1.09% |
| 22 | Bright Minds Biosciences Inc | DRUG | 251,572 | $9.1M | 1.02% |
| 23 | Olema Pharmaceuticals Inc | OLMA | 1,505,862 | $8.8M | 0.98% |
| 24 | Cogent Biosciences Inc | COGT | 1,122,471 | $8.8M | 0.98% |
| 25 | Celcuity Inc | CELC | 610,500 | $8.0M | 0.90% |
| 26 | Verastem Inc | VSTM | 1,538,461 | $8.0M | 0.89% |
| 27 | Unicycive Therapeutics | UNCY | 9,970,152 | $7.9M | 0.89% |
| 28 | Regulus Therapeutics Inc | 75915K309 | 5,000,000 | $7.9M | 0.89% |
| 29 | Silence Therapeutics PLC | SLNCF | 1,105,454 | $7.6M | 0.85% |
| 30 | Compass Pathway PLC | CMPS | 1,608,000 | $6.1M | 0.68% |
| 31 | IO Biotech Inc | IOBT | 6,173,439 | $5.7M | 0.64% |
| 32 | Aligos Therapeutics Inc | ALGS | 141,879 | $5.7M | 0.63% |
| 33 | Compass Therapeutics Inc | CMPX | 3,556,023 | $5.2M | 0.58% |
| 34 | Allakos Inc | 01671P100 | 2,956,110 | $3.6M | 0.40% |
| 35 | Corbus Pharmaceuticals Holdings | CRBP | 166,794 | $2.0M | 0.22% |
| 36 | Bolt Therapeutics Inc | BOLT | 3,521,291 | $1.9M | 0.21% |
| 37 | Tenax Therapeutics Inc | TENX | 208,333 | $1.3M | 0.14% |
| 38 | DBV Technologies SA | DBVTF | 32,020 | $98,942 | 0.01% |
| 39 | Q32 Bio Inc. | QTTB | 20,559 | $70,723 | 0.01% |
| 40 | Precision Biosciences Inc | DTIL | 4,675 | $17,812 | 0.00% |